Interleukin-6-dependent survival of multiple myeloma cells involves the Stat3-mediated induction of micro-RNA-21 through a highly conserved enhancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Blood, Erscheinungsort: Washington, Verlag: American Society of Hematology, Erscheinungsjahr: 2007, Jahrgang: 110, Heft: 4, Seiten: 1330-1333, ISSN: 0006-4971, E-ISSN: 1528-0020
- Event
-
Veröffentlichung
- (where)
-
Leipzig
- (who)
-
Universitätsbibliothek Leipzig
- (when)
-
2018
- Creator
-
Löffler, Dennis
Brocke-Heidrich, Katja
Pfeifer, Gabriele
Stocsits, Claudia
Hackermüller, Jörg
Kretzschmar, Antje K.
Burger, Renate
Gramatzki, Martin
Blumert, Conny
Bauer, Kay
Cvijic, Helena
Ullmann, Kerstin
Stadler, Peter F.
Horn, Friedemann
- URN
-
urn:nbn:de:bsz:15-qucosa2-321287
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:44 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Löffler, Dennis
- Brocke-Heidrich, Katja
- Pfeifer, Gabriele
- Stocsits, Claudia
- Hackermüller, Jörg
- Kretzschmar, Antje K.
- Burger, Renate
- Gramatzki, Martin
- Blumert, Conny
- Bauer, Kay
- Cvijic, Helena
- Ullmann, Kerstin
- Stadler, Peter F.
- Horn, Friedemann
- Universitätsbibliothek Leipzig
Time of origin
- 2018
Other Objects (12)
Multiple myeloma
Mechanismen distaler Enhancer
Conserved RNA Pseudoknots
Conserved charge fluctuations are not conserved during the hadronic phase
Mechanisms of enhancer regulation
Subnucleäre Lokalisation des Transkriptionsfaktors STAT3
STAT3 inhibitors for cancer treatment
STAT3 inhibitors for cancer treatment
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Characterization of the CD83 promoter-enhancer complex : = Charakterisierung des CD83 Promotor-Enhancer- Komplexes
STAT3 targeting in dystrophic epidermolysis bullosa
Multiple myeloma
Mechanismen distaler Enhancer
Conserved RNA Pseudoknots
Conserved charge fluctuations are not conserved during the hadronic phase
Mechanisms of enhancer regulation
Subnucleäre Lokalisation des Transkriptionsfaktors STAT3
STAT3 inhibitors for cancer treatment
STAT3 inhibitors for cancer treatment
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Characterization of the CD83 promoter-enhancer complex : = Charakterisierung des CD83 Promotor-Enhancer- Komplexes
STAT3 targeting in dystrophic epidermolysis bullosa
Multiple myeloma
Mechanismen distaler Enhancer
Conserved RNA Pseudoknots
Conserved charge fluctuations are not conserved during the hadronic phase
Mechanisms of enhancer regulation
Subnucleäre Lokalisation des Transkriptionsfaktors STAT3
STAT3 inhibitors for cancer treatment
STAT3 inhibitors for cancer treatment
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Characterization of the CD83 promoter-enhancer complex : = Charakterisierung des CD83 Promotor-Enhancer- Komplexes